Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
InMed Pharmaceuticals ( (INM) ) just unveiled an update.
InMed Pharmaceuticals Inc. announced that Ms. Janet Grove’s resignation from the Board of Directors was accepted on February 10, 2025, following the withholding of her election by the company’s shareholders at the 2024 Annual General Meeting on December 18, 2024. The Board will seek an independent director to replace Ms. Grove, while the Board Chair will temporarily assume her role as Chair of the Nominating & Governance Committee.
More about InMed Pharmaceuticals
YTD Price Performance: -35.42%
Average Trading Volume: 495,220
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $3.74M
See more insights into INM stock on TipRanks’ Stock Analysis page.